Alps Advisors Inc. increased its position in HealthEquity by 0.3% in the second quarter. 579,253 shares of the stock traded hands. Creative Planning's holdings in HealthEquity were worth $163,000 as of its most recent SEC filing.
Institutional investors have recently bought and sold shares of the company. As of the end of the quarter Columbia Wanger Asset Management LLC had acquired 14,103 shares growing its holdings by 7.1%. Raging Capital Management Llc owns 2.55 million shares or 1.14% of their U.S. portfolio. Teachers Retirement System of The State of Kentucky increased its position in shares of HealthEquity by 13.3% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 22,039 shares of the company's stock valued at $893,000 after buying an additional 590 shares during the last quarter. Arcadia Investment Management Corp MI now owns 2,515 shares of the company's stock valued at $107,000 after buying an additional 1,131 shares during the period. Finally, UBS Group AG boosted its stake in HealthEquity by 59.5% in the first quarter. Td Asset Management reported 0% in Autoliv Inc. Elkfork Partners LLC now owns 55,944 shares of the company's stock valued at $2,375,000 after buying an additional 196 shares during the last quarter. Institutional investors own 90.35% of the company's stock.
Shares of HealthEquity, Inc. (HQY) traded down 2.62% during trading on Friday, reaching $44.93. For the next financial year, analysts forecast that the company will report earnings of $0.69 per share, with EPS estimates ranging from $0.63 to $0.76. The company's 50-day moving average price is $48.74 and its 200 day moving average price is $46.12. The company has market cap of $2.76 billion.
HealthEquity, Inc. has a 1-year low of $28.33 and a 1-year high of $54.95.
Other equities analysts have also issued research reports about the stock. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The firm had revenue of $55.40 million during the quarter, compared to analysts' expectations of $54.77 million. During the same quarter past year, the company earned $0.15 earnings per share. HealthEquity's revenue was up 25.9% compared to the same quarter a year ago. On average, equities analysts anticipate that HealthEquity, Inc. will post $0.58 EPS for the current fiscal year.
Mourinho eyes second season glory with Manchester United
However, the United manager is confident that his team can improve on that, having had a good pre-season and are well prepared. United have been outspent by neighbours Manchester City but Mourinho has warned them it takes more than cash to be a victor .
COPYRIGHT VIOLATION WARNING: This story was originally reported by Week Herald and is owned by of Week Herald. If you are accessing this article on another publication, it was copied illegally and republished in violation of global trademark and copyright law. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/08/12/oppenheimer-asset-management-inc-invests-106000-in-healthequity-inc-hqy-updated-updated-updated.html. The firm earned "Outperform" rating on Tuesday, December 8 by Barrington Research. Oppenheimer Holdings, Inc. restated an outperform rating and set a $61.00 price target (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Zacks Investment Research cut HealthEquity from a "buy" rating to a "hold" rating in a research report on Friday, August 4th. Finally, J P Morgan Chase & Co raised their price objective on HealthEquity from $44.00 to $51.00 and gave the company an overweight rating in a research note on Wednesday, March 22nd.
(NASDAQ:HQY) shares saw heavy trading volume with 576K shares changing hands in the last trading session. Chardan Capital increased their price target on shares of HealthEquity from $53.00 to $57.00 and gave the company a "buy" rating in a research report on Wednesday, June 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company's stock. HealthEquity presently has an average rating of "Buy" and a consensus price target of $50.22.
In related news, VP Ashley Dreier sold 10,000 shares of the company's stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $47.81, for a total transaction of $478,100.00. Following the completion of the sale, the vice president now directly owns 15,652 shares in the company, valued at $748,322.12. (NASDAQ:HQY) recently. Stephen Neeleman, Founder and Vice Chairman disclosed the sale of 8,500 shares. In the last quarter, insiders sold 2,440,821 shares of company stock worth $125,325,268.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators.
According to Zacks, "HealthEquity, Inc.is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions".